JP2013034479A5 - - Google Patents

Download PDF

Info

Publication number
JP2013034479A5
JP2013034479A5 JP2012202509A JP2012202509A JP2013034479A5 JP 2013034479 A5 JP2013034479 A5 JP 2013034479A5 JP 2012202509 A JP2012202509 A JP 2012202509A JP 2012202509 A JP2012202509 A JP 2012202509A JP 2013034479 A5 JP2013034479 A5 JP 2013034479A5
Authority
JP
Japan
Prior art keywords
base sequence
cell
base
seq
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012202509A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013034479A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012202509A priority Critical patent/JP2013034479A/ja
Priority claimed from JP2012202509A external-priority patent/JP2013034479A/ja
Publication of JP2013034479A publication Critical patent/JP2013034479A/ja
Publication of JP2013034479A5 publication Critical patent/JP2013034479A5/ja
Pending legal-status Critical Current

Links

JP2012202509A 2010-07-12 2012-09-14 miRNA導入による新規hiPSC作製法 Pending JP2013034479A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012202509A JP2013034479A (ja) 2010-07-12 2012-09-14 miRNA導入による新規hiPSC作製法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2010158192 2010-07-12
JP2010158193 2010-07-12
JP2010158193 2010-07-12
JP2010158194 2010-07-12
JP2010158194 2010-07-12
JP2010158192 2010-07-12
JP2012202509A JP2013034479A (ja) 2010-07-12 2012-09-14 miRNA導入による新規hiPSC作製法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011530189A Division JP5099571B2 (ja) 2010-07-12 2011-06-28 miRNA導入による新規hiPSC作製法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013264240A Division JP5845493B2 (ja) 2010-07-12 2013-12-20 miRNA導入による新規hiPSC作製法

Publications (2)

Publication Number Publication Date
JP2013034479A JP2013034479A (ja) 2013-02-21
JP2013034479A5 true JP2013034479A5 (https=) 2014-08-21

Family

ID=45469308

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2011530189A Expired - Fee Related JP5099571B2 (ja) 2010-07-12 2011-06-28 miRNA導入による新規hiPSC作製法
JP2011530188A Expired - Fee Related JP5099570B2 (ja) 2010-07-12 2011-06-28 siRNA導入による新規hiPSC作製法
JP2012202508A Pending JP2013046616A (ja) 2010-07-12 2012-09-14 siRNA導入による新規hiPSC作製法
JP2012202509A Pending JP2013034479A (ja) 2010-07-12 2012-09-14 miRNA導入による新規hiPSC作製法
JP2013264240A Expired - Fee Related JP5845493B2 (ja) 2010-07-12 2013-12-20 miRNA導入による新規hiPSC作製法

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2011530189A Expired - Fee Related JP5099571B2 (ja) 2010-07-12 2011-06-28 miRNA導入による新規hiPSC作製法
JP2011530188A Expired - Fee Related JP5099570B2 (ja) 2010-07-12 2011-06-28 siRNA導入による新規hiPSC作製法
JP2012202508A Pending JP2013046616A (ja) 2010-07-12 2012-09-14 siRNA導入による新規hiPSC作製法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013264240A Expired - Fee Related JP5845493B2 (ja) 2010-07-12 2013-12-20 miRNA導入による新規hiPSC作製法

Country Status (5)

Country Link
US (2) US9476041B2 (https=)
EP (2) EP2594643B1 (https=)
JP (5) JP5099571B2 (https=)
CN (2) CN103189511B (https=)
WO (2) WO2012008301A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103189511B (zh) 2010-07-12 2016-10-12 国立大学法人鸟取大学 利用siRNA导入的新型hiPSC制作法
EP2686418A4 (en) 2011-03-17 2015-04-22 Minerva Biotechnologies Corp METHOD FOR THE PRODUCTION OF PLURIPOTENTAL STEM CELLS
EP2768945B1 (en) 2011-10-17 2022-01-05 Minerva Biotechnologies Corporation Media for stem cell proliferation and induction
EP2844744A2 (en) * 2012-02-22 2015-03-11 Brainstem Biotec Ltd. MicroRNAS FOR THE GENERATION OF ASTROCYTES
JP6748430B2 (ja) * 2012-07-13 2020-09-02 ミネルバ バイオテクノロジーズ コーポレーション より未分化状態への細胞の誘導方法
JPWO2015030149A1 (ja) * 2013-08-29 2017-03-02 国立大学法人鳥取大学 細胞のアンチエイジングに関連する生体分子群
TW201610152A (zh) * 2013-11-22 2016-03-16 國立臺灣大學 微rna146-a及其於診斷、治療及預防小核醣核酸病毒感染之用途及微rna146-a拮抗劑
CN104109670B (zh) * 2014-03-12 2018-01-05 首都医科大学附属北京安定医院 一种双链siRNA分子及其应用
AU2015278699B2 (en) 2014-06-27 2019-10-31 Rhizen Pharmaceuticals Sa Substituted chromene derivatives as selective dual inhibitors of PI3 delta and gamma protein kinases
US10806748B2 (en) 2015-04-24 2020-10-20 The Johns Hopkins University Compositions and methods related to characterizing proviral reservoirs
US20180311270A1 (en) * 2015-10-30 2018-11-01 Norimasa Miura Rna molecule for repairing dna damage
KR102011336B1 (ko) * 2015-12-31 2019-08-16 인터올리고 주식회사 약물 전달 및 안정화를 위한 복합체 및 그 제조방법
WO2018203553A1 (ja) * 2017-05-02 2018-11-08 株式会社ペジィー・ファーマ 分化細胞の品質改善方法
WO2023128862A1 (en) * 2021-12-29 2023-07-06 Livius Pte. Ltd. Method for repairing hair cycle-related genes and method for treating hair cycle-related diseases using mir-520d-5p
JP2023149907A (ja) * 2022-03-31 2023-10-16 株式会社島津製作所 微生物情報の提供方法および微生物検査システム

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467258A1 (en) * 2001-11-15 2003-05-22 Kyowa Hakko Kogyo Co., Ltd. Agent for inducing embryonic stem cell to ectodermal cell, method for obtaining the same and use of the same.
AU2003270734A1 (en) 2002-09-16 2004-04-30 University Of Southern California Rna-mediated gene modulation
JP2006519008A (ja) 2003-02-10 2006-08-24 独立行政法人産業技術総合研究所 哺乳動物細胞の調節
US9453219B2 (en) * 2003-05-15 2016-09-27 Mello Biotech Taiwan Co., Ltd. Cosmetic designs and products using intronic RNA
CA2857881A1 (en) * 2004-11-12 2006-12-28 Asuragen, Inc. Methods and compositions involving mirna and mirna inhibitor molecules
MX2007009417A (es) 2005-02-04 2007-08-17 Univ Auburn Sistema de suministro de farmaco de contacto.
WO2006112239A1 (ja) 2005-04-15 2006-10-26 National University Corporation Tottori University hTERT発現調節遺伝子
PL2002003T3 (pl) * 2005-05-27 2016-06-30 Ospedale San Raffaele Srl Wektor genetyczny zawierający mi-RNA
WO2006137514A1 (ja) 2005-06-23 2006-12-28 Locomogene, Inc. シノビオリンの発現もしくは機能阻害物質を有効成分とする癌治療剤、および癌治療剤のスクリーニング方法
BRPI0619794B8 (pt) 2005-12-13 2022-06-14 Univ Kyoto Uso de um fator de reprogramação, agente para a preparação de uma célula-tronco pluripotente induzida a partir de uma célula somática e métodos para preparar uma célula- tronco pluripotente induzida método e para preparar uma célula somática e uso de células-tronco pluripotentes induzidas
EP2487258B1 (en) * 2006-01-05 2014-10-01 The Ohio State University Research Foundation MicroRNA-based methods for the diagnosis of colon, pancreas and stomach cancer
CA2648132C (en) 2006-04-03 2019-05-28 Santaris Pharma A/S Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
EP2217248B1 (en) * 2007-10-29 2016-11-30 Regulus Therapeutics Inc. Targeting micrornas for the treatment of liver cancer
AU2008297024B2 (en) 2007-10-31 2014-08-28 Kyoto University Nuclear reprogramming method
JP5558097B2 (ja) 2007-12-10 2014-07-23 国立大学法人京都大学 効率的な核初期化方法
WO2009082817A1 (en) * 2007-12-27 2009-07-09 Protiva Biotherapeutics, Inc. Silencing of polo-like kinase expression using interfering rna
WO2009091659A2 (en) * 2008-01-16 2009-07-23 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents
CN101333524B (zh) * 2008-06-25 2010-06-02 中山大学 一个小分子非编码RNA基因hsa-miR-101及其抗肿瘤用途
CN101392251B (zh) * 2008-11-03 2015-07-22 清华大学深圳研究生院 能诱导干细胞向成骨细胞分化的微小rna及其应用
JP2010120881A (ja) * 2008-11-19 2010-06-03 Keio Gijuku ヒト癌タンパク質MDM2とヒト癌抑制タンパク質p53との相互作用阻害ペプチド及びその使用
CN103189511B (zh) 2010-07-12 2016-10-12 国立大学法人鸟取大学 利用siRNA导入的新型hiPSC制作法

Similar Documents

Publication Publication Date Title
JP2013034479A5 (https=)
JP2013046616A5 (https=)
PH12020551744A1 (en) Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
MY176332A (en) Multispecific antibody constructs
NZ742040A (en) Engineered nucleic-acid targeting nucleic acids
EA201590488A1 (ru) Способы модификации клеток-хозяев
JP2014533491A5 (https=)
BR112015023036A2 (pt) método para preparar um produto alcaloide benzilisoquinolina e célula microbiana engenheirada que produz um produto alcaloide benzilisoquinolina
WO2016183438A8 (en) Self-targeting genome editing system
CY1122275T1 (el) Μεσεγχυματικα στρωματικα κυτταρα και χρησεις που σχετιζονται με αυτα
EA201100225A1 (ru) Новые регуляторные элементы
MX2022003116A (es) Factor ix modificado, y composiciones, metodos y usos para la transferencia de genes a celulas, organos y tejidos.
WO2008064839A3 (en) Method for preparing hydroxytyrosol
MX2021000211A (es) Metodos y productos para transfeccion de celulas.
MX367100B (es) Composiciones del vector aav y metodos para su transferencia genetica a celulas, organos y tejidos.
EA201492121A1 (ru) Композиции и способы для модулирования экспрессии семейства генов гемоглобина
IN2014DN10996A (https=)
MX2014001383A (es) Colageno 7 y metodos relacionados.
MX2018009375A (es) Genes del factor viii optimizados.
EA201990549A1 (ru) Трихома-специфичные промоторы для регулирования каннабиноидов и других соединений в железистых трихомах
NZ591662A (en) Vector comprising multiple homologous nucleotide sequences
WO2012075462A3 (en) Methods and compositions for treatment of muscular dystrophy
MX2010001491A (es) Proteina precursora de tiopeptidos, gen que la codifica, y usos de la misma.
DE60334382D1 (de) Verfahren zur herstellung von temperaturinduzierten tumorzell-lysaten zur verwendung als immunogene verbindungen
EA032977B1 (ru) Генетически стабильный онколитический рнк вирус, способ его производства и применения